Lighthouse Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel small-molecule therapies for neurodegenerative and inflammatory diseases. The company is advancing its lead program, LHP588, through a Phase 2 SPRING trial targeting P. gingivalis-positive mild to moderate Alzheimer's disease while continuing to expand its therapeutic pipeline.
Leadership & Board
Current Number of Employees12
Current LinkedIn Followers775
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$12M
Total Amount Raised$12M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$12M
Latest Funding Amount$12M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Lighthouse Pharmaceuticals had 12 employees as of September 14, 2026. The number of employees increased by 0 (0.00%) week-over-week.
12Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Lighthouse Pharmaceuticals had 775 followers as of September 14, 2026. The number of followers increased by 6 (0.78%) week-over-week.
775Latest Followers Count
6(0.78%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.